US Stock MarketDetailed Quotes
ENTO Entero Therapeutics
- 0.465
- -0.006-1.23%
Close Nov 26 16:00 ET
- 0.465
- 0.0000.00%
Post 18:01 ET
2.21MMarket Cap0.03P/E (TTM)
0.482High0.450Low58.82KVolume0.482Open0.471Pre Close27.23KTurnover1.26%Turnover RatioLossP/E (Static)4.75MShares14.51052wk High0.26P/B2.18MFloat Cap0.18552wk Low--Dividend TTM4.68MShs Float235200.000Historical High--Div YieldTTM6.79%Amplitude0.185Historical Low0.462Avg Price1Lot Size
Entero Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 44.51%-1.85M | -24.95%-3.45M | -31.68%-3.75M | 44.60%-12.38M | 38.50%-3.44M | 21.69%-3.33M | 39.77%-2.76M | 64.03%-2.85M | 30.80%-22.34M | 4.61%-5.59M |
| Net income from continuing operations | 24.84%-2.58M | -110.25%-8.81M | 236.77%5.57M | -7.97%-15.79M | -2.88%-4.1M | -178.20%-3.43M | 22.54%-4.19M | 57.72%-4.07M | 75.01%-14.63M | 64.32%-3.99M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 20.47%1.71M | ---- |
| Depreciation and amortization | -81.74%1.34K | 382.54%35.32K | 67.98%12.29K | 0.01%29.27K | 0.01%7.32K | 0.00%7.32K | 0.01%7.32K | 0.01%7.32K | -94.60%29.27K | -94.67%7.32K |
| Deferred tax | --0 | --4.26M | ---14.86M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other non cash items | -81.18%17.33K | 4,876.12%786.53K | 30,879.68%4.81M | -43.40%157.02K | -65.28%33.59K | 514.83%92.1K | -32.75%15.81K | -89.08%15.53K | -91.99%277.43K | -96.40%96.76K |
| Change In working capital | 304.07%530.17K | -86.70%147.86K | -46.54%451.15K | 120.86%2.19M | 114.10%494.53K | 97.03%-259.8K | 166.72%1.11M | -37.35%843.91K | -161.41%-10.5M | -151.86%-3.51M |
| -Change in receivables | --0 | --0 | --0 | 200.00%93.01K | --0 | --0 | 147.20%20K | 360.25%73.01K | -116.87%-93.01K | --98.97K |
| -Change in prepaid assets | -64.82%152.48K | 4.95%351.18K | -37.75%318.34K | 575.68%719.26K | 27.78%-560.19K | 19,337.85%433.46K | 26.96%334.6K | 42.55%511.39K | -337.02%-151.21K | 12.29%-775.73K |
| -Change in payables and accrued expense | 161.69%405.46K | -121.63%-163.4K | -53.73%127.36K | 114.31%1.45M | 138.31%1.08M | 92.38%-657.23K | 235.58%755.57K | -74.19%275.27K | -161.81%-10.15M | -484.13%-2.82M |
| -Change in other current liabilities | 22.92%-27.77K | -2,675.03%-39.91K | 134.53%5.44K | 33.64%-74.05K | -66.53%-23.8K | -103.97%-36.04K | 105.25%1.55K | 68.55%-15.77K | -258.74%-111.6K | 44.46%-14.29K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 44.51%-1.85M | -24.95%-3.45M | -31.68%-3.75M | 44.60%-12.38M | 38.50%-3.44M | 21.69%-3.33M | 39.77%-2.76M | 64.03%-2.85M | 30.80%-22.34M | 4.61%-5.59M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 88.17K | -500K | -500K | 0 | 0 | 0 | 0 | |
| Net intangibles purchase and sale | ---- | ---- | ---- | ---500K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net business purchase and sale | --0 | --0 | --88.17K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --88.17K | ---500K | ---500K | --0 | --0 | --0 | --0 | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -71.18%1.55M | -64.75%681.42K | -4.74%3.38M | -3.26%15.23M | -21.10%4.36M | 12.90%5.39M | 2,431.33%1.93M | -33.91%3.55M | -64.84%15.74M | -67.64%5.52M |
| Net issuance payments of debt | -15.69%-177.56K | 7.80%-209.21K | -1.30%-226.02K | 5.89%-603.49K | --0 | 5.21%-153.48K | 5.79%-226.91K | 6.44%-223.1K | -821.86%-641.24K | --0 |
| Net common stock issuance | --0 | 1,228.21%890.59K | -4.38%3.6M | -31.32%15.83M | 39.53%10.3M | -75.13%1.83M | -124.88%-78.94K | -52.71%3.77M | -29.44%23.05M | 19.47%7.39M |
| Net preferred stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -97.20%199K | ---1 |
| Proceeds from stock option exercised by employees | -53.32%1.73M | -100.00%36 | -97.01%9 | -98.64%657 | -1,464,564.53%-5.95M | 790,489.77%3.71M | --2.24M | -99.38%301 | -99.01%48.42K | --406 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---6.91M | ---1.86M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -71.18%1.55M | -64.75%681.42K | -4.74%3.38M | -3.26%15.23M | -21.10%4.36M | 12.90%5.39M | 2,431.33%1.93M | -33.91%3.55M | -64.84%15.74M | -67.64%5.52M |
| Net cash flow | ||||||||||
| Beginning cash position | -45.61%684K | 65.56%3.45M | 169.66%3.73M | -83.22%1.38M | 97.43%3.31M | 8.88%1.26M | -63.37%2.09M | -83.22%1.38M | 36.07%8.25M | -76.72%1.68M |
| Current changes in cash | -114.38%-295.69K | -234.32%-2.77M | -139.89%-279.86K | 135.56%2.35M | 716.38%419.44K | 297.22%2.06M | 81.63%-828.38K | 127.57%701.53K | -406.36%-6.6M | -107.07%-68.05K |
| Effect of exchange rate changes | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -944.43%-259.71K | -397.39%-226.05K |
| End cash Position | -88.28%388.31K | -45.61%684K | 65.56%3.45M | 169.66%3.73M | 169.66%3.73M | 97.43%3.31M | 8.88%1.26M | -63.37%2.09M | -83.22%1.38M | -83.22%1.38M |
| Free cash flow | 44.51%-1.85M | -24.95%-3.45M | -31.68%-3.75M | 42.37%-12.88M | 29.56%-3.94M | 21.69%-3.33M | 39.77%-2.76M | 64.03%-2.85M | 47.56%-22.34M | 65.29%-5.59M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data